Table 1 Treatment choices and treatment outcomes.
From: Comprehensive analysis of 65 patients with Castleman disease in a single center in China
UCD | MCD | Total | |
|---|---|---|---|
Treatment, n (%) | 33 (50.8%) | 32 (49.2%) | 65 |
SE | 31 (93.9%) | 15 (46.9%) | 46 (70.8%) |
SE + RT | 0 | 1 (3.1%) | 1 (1.5%) |
SE + CT | 2 (6.1%) | 16 (50.0%) | 18 (27.7%) |
Follow-up time (months), median, n (%) | 53.0, 33 (50.8%) | 79.5, 32 (49.2%) | 66.0, 65 |
Recurrence, n (%) | 0 | 2 (6.3%) | 2 (3.1%) |
Survival, n (%) | 33 (100%) | 29 (90.6%) | 62 (95.4%) |
